The closing price of Keros Therapeutics Inc (NASDAQ: KROS) was $65.94 for the day, down -1.35% from the previous closing price of $66.84. In other words, the price has decreased by -$0.90 from its previous closing price. On the day, 593241 shares were traded.
Ratios:
Our analysis of KROS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 14.25 and its Current Ratio is at 14.25. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $60.
On July 31, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $86.Wedbush initiated its Outperform rating on July 31, 2023, with a $86 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 04 ’23 when Regnante Keith sold 40,000 shares for $45.29 per share. The transaction valued at 1,811,600 led to the insider holds 0 shares of the business.
Regnante Keith sold 20,000 shares of KROS for $908,367 on Jun 09 ’23. The Chief Financial Officer now owns 0 shares after completing the transaction at $45.42 per share. On Jun 08 ’23, another insider, Regnante Keith, who serves as the Chief Financial Officer of the company, sold 20,000 shares for $47.79 each. As a result, the insider received 955,872 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KROS now has a Market Capitalization of 2.37B and an Enterprise Value of 2.06B. For the stock, the TTM Price-to-Sale (P/S) ratio is 15816.81 while its Price-to-Book (P/B) ratio in mrq is 6.32. Its current Enterprise Value per Revenue stands at 13.62k whereas that against EBITDA is -13.51.
Stock Price History:
Over the past 52 weeks, KROS has reached a high of $73.00, while it has fallen to a 52-week low of $27.02. The 50-Day Moving Average of the stock is 54.41, while the 200-Day Moving Average is calculated to be 40.75.
Shares Statistics:
KROS traded an average of 471.99K shares per day over the past three months and 381.72k shares per day over the past ten days. A total of 31.84M shares are outstanding, with a floating share count of 26.71M. Insiders hold about 25.76% of the company’s shares, while institutions hold 70.39% stake in the company. Shares short for KROS as of Feb 15, 2024 were 1.78M with a Short Ratio of 3.77, compared to 1.45M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.97% and a Short% of Float of 7.16%.
Earnings Estimates
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$1.34 for the current quarter, with a high estimate of -$1.2 and a low estimate of -$1.62, while EPS last year was -$1.26. The consensus estimate for the next quarter is -$1.33, with high estimates of -$1.1 and low estimates of -$1.7.
Analysts are recommending an EPS of between -$4.17 and -$6.3 for the fiscal current year, implying an average EPS of -$5.21. EPS for the following year is -$5.5, with 10 analysts recommending between -$4.4 and -$6.98.
